摘要:
The present invention provides the use of a CNS-penetrant NK-1 receptor antagonist in an oral, once-a-day medicament for the treatment of major depressive disorder, methods of treatment using such a NK-1 receptor antagonist and pharmaceutical compositions comprising it.
摘要:
The present invention relates to compounds of formula (I): wherein X is N or CH; and pharmaceutically acceptable salts and prodrugs thereof. The compounds are of particular use in the treatment of pain, inflammation, migraine and emesis.
摘要:
The present invention provides the use of an orally active, long acting, CNS-penetrant NK-1 receptor antagonist for the manufacture of a medicament adapted for oral administration for the treatment or prevention of cognitive disorders, methods of medical treatment using such an NK-1 receptor antagonist and pharmaceutical compositions comprising it.
摘要:
The present invention provides the use of a CNS-penetrant NK-1 receptor antagonist in an oral, once-a-day medicament for the treatment of major depressive disorder, methods of treatment using such a NK-1 receptor antagonist and pharmaceutical compositions comprising it.
摘要:
The present invention provides the use of an orally active, long acting, CNS-penetrant NK-1 receptor antagonist for the manufacture of a medicament adapted for oral administration for the treatment or prevention of substance use disorders, methods of treatment using such a NK-1 receptor antagonist and pharmaceutical compositions comprising the same.
摘要:
The present invention relates compounds of formula (I), wherein ring A is a phenyl or pyridyl ring; X represents a linker selected from the group consisting of formulae: (a), (b), (c), (d), and (e); and R?1, R2, R3, R4, R5, R6, R7, R13, R14, R15, R16, R17, R21a and R21b¿ are as defined herein. The compounds are of particular use in the treatment or prevention of depression, anxiety, pain, inflammation, migraine, emesis or postherpetic neuralgia.
摘要翻译:本发明涉及式(I)的化合物,其中环A是苯基或吡啶环; X表示选自式(a),(b),(c),(d)和(e)的连接体。 和R 1,R 2,R 3,R 4,R 5, R 6,R 7,R 13,R 14,R 15, R 16,R 17,R 21a和R 21b如本文所定义。 这些化合物特别用于治疗或预防抑郁,焦虑,疼痛,炎症,偏头痛,呕吐或带状疱疹后神经痛。
摘要:
The present invention relates to compounds of formula (I), wherein R is C1-6alkyl, C2-6alkenyl, C2-6alkynyl, C3-7cycloalkyl, C3-7cycloalyklC1-4alkyl, which groups are optionally substituted by hydroxy, C1-4alkoxy or NRaRb, where R?a and Rb¿ each independently represent hydrogen or C¿1-4?alkyl; or R is C1-4alkyl substituted by Ar, and optionally further substituted by one or both of R?4 and R5; R1, R2 and R3¿ represent a variety of substituents; R?9 and R10¿ are each hydrogen, halogen, C¿1-6?alkyl, CH2OR?e¿, oxo, CO¿2R?a or CONRaRb where Re represents hydrogen, C¿1-6?alkyl or phenyl; X is -CH2, or -CH2CH2-; Y is -CH=, -CH2-, -CH2CH= or -CH2CH2-, with the proviso that the sum total of carbon atoms in X+Y is 2 or 3; and when Y is -CH= or -CH2CH=, the broken line is a double bond; or a pharmaceutically acceptable salt thereof. The compounds are of particular use in the treatment or prevention of pain, inflammation, migraine, emesis and postherpetic neuralgia.
摘要:
The present invention relates to compounds of formula (I), wherein R?1, R2, R4, R5 and R6¿ represent a variety of substituents; R3 represents an optionally substituted 5- or 6- membered aromatic heterocyclic group containing 1, 2, 3 or 4 heteroatoms, selected from nitrogen, oxygen and sulphur. R?9a and R9b¿ each independently represent hydrogen or C¿1-4?alkyl, or R?9a and R9b¿ are joined so, together with the carbon atoms to which they are attached, there is formed a C¿5-7? ring; m is zero, 1, 2 or 3; and n is zero, 1, 2 or 3; with the proviso that the sum total of m and n is 2 or 3; or a pharmaceutically acceptable salt thereof. The compounds are of particular use in the treatment or prevention of pain, inflammation, migraine, emesis and postherpetic neuralgia.
摘要:
Composés de formule (I) et leurs sels et promédicaments où n vaut 1, 2 ou 3; R1 représente phényle éventuellement substitué; R2 représente aryle, hétéroaryle, benzhydryle ou benzyle; R4 et R5 représentent chacun indépendamment H, halo, CH2OR9, C1-6alkyle, oxo, CO2R10 ou CONR10R11; R8 représente H, COR9, CO2R10 ou C1-6alkyle éventuellement substitué; R9 représente H, C1-6alkyle ou phényle; et R10 et R11 représentent chacun indépendamment H ou C1-6alkyle. Ces composés sont des antagonistes de la tachykinine. Comme les compositions qui les contiennent, ils sont utiles en médecine.
摘要:
The present invention relates compounds of formula (I), wherein ring A is a phenyl or pyridyl ring; X represents a linker selected from the group consisting of formulae: (a), (b), (c), (d), and (e); and R?1, R2, R3, R4, R5, R6, R7, R13, R14, R15, R16, R17, R21a and R21b¿ are as defined herein. The compounds are of particular use in the treatment or prevention of depression, anxiety, pain, inflammation, migraine, emesis or postherpetic neuralgia.